Suzette Girgis

Strong drug development experience (more than 25 years) in small molecule, cell therapy and biologics (including bispecifics such as BCMA, GPRC5D & HER2) at early and late stage of development, including filing and registration across different therapeutic areas with emphasis on oncology. Expert in applying quantitative medicine approaches for strategic decision making and selecting the dose regimen for First in Human and the Proof of Concept studies. Solid clinical experience in study execution and data interpretation. Strong managerial and mentoring experience. Influential leadership skills. Oversee the clinical pharmacology strategy of oncology and neuroscience compounds. Significant contributions to various compounds submissions (such as Ziihera, Tecvayli, Talvey, Velcade, Dacogen, Nulojix). Due Diligence activities. Business and operation strategies. Hold 3 patents (teclistamab, talquetamab, soluble BCMA).